Leading specialists in pulmonology have formed Healio Pulmonology’s Peer Perspective Board to help guide coverage and provide ...

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

Pulmonologists share best practices on when primary care providers should consider sending patients with respiratory illnesses to a specialist.

Center for Pulmonary Vascular Biology and Medicine, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, Division of Cardiology, Department of Medicine, University of Pittsburgh, School of ...

This fundamental research conducted a molecular comparison between smooth muscle cells and adjacent fibroblast cells within lung blood vessels affected by pulmonary arterial hypertension. The study ...

Researchers recruited patients from the London COPD Exacerbation Cohort to examine how levels of SPMs, particularly RvD1, in the sputum of patients with COPD change over time during exacerbations ...

U.S. Education Secretary Linda McMahon, who is dismantling the department she leads, said Tuesday that she supports ongoing national student testing and a role for the federal government in ...

The following is a summary of “Association of cardiovascular health with COPD (NHANES 2007-2020): mediating potential of lean body mass,” published in the April 2025 issue of Frontiers in ...

Get Instant Summarized Text (Gist) Pulmonary artery denervation (PADN) shows promise as an intervention for pulmonary hypertension, improving key hemodynamic parameters and clinical outcomes. A ...

Dupilumab decreased exacerbations in those with COPD and T2 inflammation by 28.2% (baseline BODE score ≤4) to 34.4% (BODE score >4) over a 1-year period. Dupilumab was associated with a decrease in ...

I’ve found the medication to be quite effective in improving my sleep. The one symptom of COPD I could never find a solution for was fatigue. I experienced some level of fatigue every day, but stayed ...